No profile data available.
Bhang Inc. (BHNGF) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Toronto, Canada.
It reported revenue of $1.27 million for fiscal year 2021, down 22.2% from fiscal year 2020, and net income of -$3.30 million. In Q3 2022 (the quarter ended September 30, 2022) revenue was $363,103, up 28.3% from a year before. Its market capitalization was $3.56 million as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2021; market data as of October 8, 2026.
Bhang Inc. operates as a cannabis consumer packaged goods company. It offers cannabis; hemp-derived cannabidiol; and terpene products, including chocolates, pre-rolls, vapes, gums, beverages, and gummies.
Bhang reported $1.27 million in revenue for fiscal year 2021, down 22.2% from $1.63 million in fiscal year 2020. In Q3 2022 revenue was $363,103.
$3.56 million as of October 8, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Oncology Pharma Inc. (ONPH), Acusphere, Inc. (ACUS), For The Earth Corp. (FTEG), Eagle Pharmaceuticals, Inc. (EGRX).